Guru P. Sonpavde, MD

Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.


Posts by Guru P. Sonpavde, MD

Cancer treatment: Is a clinical trial right for you?

Some people undergoing cancer treatment may be eligible to participate in a clinical trial of a new drug or therapy. These trials help determine whether a new approach is more effective than standard treatment.

Immunotherapy: What you need to know

Immunotherapy has emerged as a viable treatment option for some advanced cancers. People considering it — and even people who have had it — have many questions.